Biologics And Small Molecule Targeted Therapies For Pediatric Alopecia Areata, Psoriasis, Atopic Dermatitis, And Hidradenitis Suppurativa In The US: A Narrative Review
July 2024
in “
Children
”
TLDR Biologics and targeted therapies could improve treatment for children with certain chronic skin conditions.
This narrative review discusses the potential of biologics and small molecule targeted therapies in treating pediatric alopecia areata, psoriasis, atopic dermatitis, and hidradenitis suppurativa in the US. The success of ongoing clinical trials could result in these therapies being included in treatment guidelines, offering new opportunities for effective disease management. These therapies enable personalized therapeutic interventions, which could significantly improve health outcomes for children suffering from these chronic skin conditions.